Neseritide therapy for the preservation of left ventricular function post anterior myocardial infarction.
Latest Information Update: 07 Aug 2020
At a glance
- Drugs Nesiritide (Primary)
- Indications Left ventricular dysfunction; Myocardial infarction
- Focus Therapeutic Use
- Acronyms BELIEVE-II
- 03 Aug 2020 Primary endpoint (Change in Left Ventricular End-Systolic Volume Index) has not been met, according to results published in the Heart
- 03 Aug 2020 Results published in the Heart
- 08 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.